Table 1 Clinical characteristics of patients.
From: Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
Variable | Non-responder (NR) (N = 11) | Responder (R) (N = 17) | Total (N = 28) |
|---|---|---|---|
Mean age (year) | 71.0 ± 12.3 | 70.0 ± 12.4 | 71.0 ± 12.1 |
Sex (%M) | 45.4 | 76.4 | 64.3 |
M stage (%) | Â | Â | Â |
 M1a | 27.3 | 23.5 | 25.0 |
 M1b | 27.3 | 35.3 | 32.1 |
 M1c | 18.2 | 29.4 | 25.0 |
 M1d | 27.3 | 11.8 | 17.8 |
LDH level (U/L) | 423.9 ± 150.0 | 401.2 ± 124.1 | 418.7 ± 134.7 |
Previous therapy (%) | 0 | 0 | 0 |
Tumor burden (cm, range) | 10.5 (2.1–43.6) | 10.5 (1.5–37.8) | 10.4 (1.5–43.6) |
